Medfine Capital
Overview
Medfine Capital is a venture capital firm that focuses on investing in early-stage and fast-growth stage companies within the life sciences and healthcare sectors . They seek to invest in areas such as biotechnology, healthcare IT, medical technologies, and pharmaceuticals .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Excalipoint Therapeutics | Mar 2026 | Seed | Co-investor |
| Phrontline Biopharma | Nov 2025 | pre_series_a_plus | Co-investor |
| Allink Biotherapeutics | Nov 2024 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Medfine Capital based?
Medfine Capital is headquartered in Shanghai, Shanghai, China.
When was Medfine Capital founded?
Medfine Capital was founded in 2014.
How many portfolio companies does Medfine Capital have?
Medfine Capital has 15 portfolio companies in Caplight's dataset.
What are some companies in Medfine Capital's portfolio?
Recent investments visible on Caplight include Excalipoint Therapeutics, Phrontline Biopharma, Phrontline Biopharma, Excalipoint Therapeutics, Allink Biotherapeutics.
What was Medfine Capital's most recent investment?
Medfine Capital's most recent investment on Caplight was in Excalipoint Therapeutics in 2026.
What sectors does Medfine Capital focus on?
Medfine Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Media, Entertainment & Gaming, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Medfine Capital focus on?
Medfine Capital typically invests at the Mid stage.
What is Medfine Capital's AUM?
Medfine Capital's assets under management are estimated between $100.0M and $250.0M.